About MCPHS/Sunovion Pharmaceuticals Inc.
Sunovion is a leading pharmaceutical company dedicated to discovering, developing, and commercializing therapeutic products that advance the science of medicine in the areas of psychiatry, neurology, and respiratory disease to improve the lives of patients and their families.
Sunovion brings together scientific focus, pragmatism, and dedication to research with an entrepreneurial energy and willingness to take on any challenge, always keeping the longer view in sight. We’ll continue to develop therapies in two distinct treatment areas—central nervous system disorders and respiratory ailments—as well as explore other therapeutic areas. We will continue to work with national and international partners to keep a constant stream of new drugs flowing into the pipeline. Because we at Sunovion put our patients front and center, we work every day to fulfill the promise of “Innovation Today, Healthier Tomorrows”.